Adaptin Bio (APTN) Shares Outstanding (2022 - 2026)

Adaptin Bio has reported Shares Outstanding (Entity) for 5 years, with the latest figure at $8.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 50.78% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (up 50.78% YoY) and the FY2025 annual result came in at $8.7 million, up 73.12% from the prior year.
• Shares Outstanding (Entity) advanced to $8.8 million in Q1 2026 per APTN's latest filing, from $8.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $8.8 million in Q1 2026 and troughed at $5.0 million in Q4 2022.
• A 5-year average of $6.3 million and a median of $5.0 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) changed 0.0% in 2023, then jumped 73.12% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then changed by 0.0% to $5.0 million in 2024, then jumped by 73.12% to $8.7 million in 2025, then advanced by 1.51% to $8.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $8.8 million, $8.7 million, and $8.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.